The Centers for Disease Control and Prevention (CDC) has identified the blood lead test as the preferred test for detecting lead exposure in children. Chronic whole blood lead levels <10 mcg/dL is often seen in children. For pediatric patients, there may be an association with blood lead values of 5 mcg/dL to 9 mcg/dL and adverse health effects. Follow up testing in 3 to 6 months may be warranted. Chelation therapy is indicated when whole blood lead concentration is >45 mcg/dL.
The Occupational Safety and Health Administration (OSHA) has published the following standards for employees working in industry:
-Employees with whole blood lead >60 mcg/dL must be removed from workplace exposure.
-Employees with whole blood lead >50 mcg/dL averaged over 3 blood samplings must be removed from workplace exposure.
-An employee may not return to work in a lead exposure environment until whole blood lead is <40 mcg/dL.
An elevated erythrocyte protoporphyrin (EP) indicates impairment of the heme biosynthetic pathway. Elevated EP levels in adults may indicate long-term lead exposure. Expected EP levels seen in heavy metal toxicity are in the range of >100 mcg/dL.